Discontinued — last reported Q1 '26
Morgan Stanley CapEx increased by 6.3% to $754.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.8%, from $713.00M to $754.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 5.9% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $514.00M | $619.00M | $650.00M | $652.00M | $799.00M | $857.00M | $770.00M | $719.00M | $851.00M | $913.00M | $929.00M | $816.00M | $851.00M | $916.00M | $879.00M | $713.00M | $763.00M | $713.00M | $709.00M | $754.00M |
| QoQ Change | — | +20.4% | +5.0% | +0.3% | +22.5% | +7.3% | -10.2% | -6.6% | +18.4% | +7.3% | +1.8% | -12.2% | +4.3% | +7.6% | -4.0% | -18.9% | +7.0% | -6.6% | -0.6% | +6.3% |
| YoY Change | — | — | — | — | +55.4% | +38.4% | +18.5% | +10.3% | +6.5% | +6.5% | +20.6% | +13.5% | +0.0% | +0.3% | -5.4% | -12.6% | -10.3% | -22.2% | -19.3% | +5.8% |